![Martina A. Sersch](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Martina A. Sersch worked as an Executive Director at Amgen, Inc. from 2016 to 2018, and as a Senior Medical Director at Genentech, Inc. from 2011 to 2016.
She also served as the Chief Medical Officer at Mustang Bio, Inc. from 2018 to 2019, and at Gracell Biotechnologies, Inc. from 2020 to 2022.
Dr. Sersch obtained her undergraduate and doctorate degrees from Ruprecht-Karls-Universität Heidelberg.
Anciens postes connus de Martina A. Sersch
| Sociétés | Poste | Fin |
|---|---|---|
| GRACELL BIOTECHNOLOGIES INC. | Directeur Technique/Scientifique/R&D | 01/08/2022 |
| MUSTANG BIO, INC. | Directeur Technique/Scientifique/R&D | 01/09/2019 |
| AMGEN INC. | Directeur/Membre du Conseil | 01/09/2018 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Directeur Technique/Scientifique/R&D | 01/01/2016 |
Formation de Martina A. Sersch
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
91
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Ruprecht-Karls-Universität Heidelberg
 Ruprecht-Karls-Universität Heidelberg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mustang Bio, Inc.
 Mustang Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops novel immunotherapy''s | Health Technology |
Gracell Biotechnologies, Inc.
 Gracell Biotechnologies, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops cell and gene therapy for the treatment of cancer and autoimmune diseases | Health Technology |
